Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19 Sell
6
-2
-25% -$8 ﹤0.01% 1098
2025
Q4
$37 Buy
+8
New +$33 ﹤0.01% 1083
2020
Q2
Sell
-25
Closed 539
2020
Q1
$0 Buy
+25
New +$373 ﹤0.01% 752
2018
Q1
Sell
-43
Closed -$1K 295
2017
Q4
$1K Buy
+43
New +$1.17K ﹤0.01% 851

Other funds holding CLLS

Inspire Investing's CLLS Position: Q1 2026 in Review

Inspire Investing reduced its Cellectis (CLLS) stake by 25% in Q1 2026, selling an estimated $8 and leaving 6 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Inspire Investing first reported a position in CLLS in Q4 2017 and has held it in 4 quarters since. The position peaked at $1K in Q4 2017. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Inspire Investing held 6 shares of Cellectis worth $19 as of Q1 2026.
  • Inspire Investing sold 2 Cellectis shares in Q1 2026, an estimated $8.
  • Cellectis made up ﹤0.01% of Inspire Investing's portfolio in Q1 2026, its #1098 holding.
  • Inspire Investing first reported a position in Cellectis in Q4 2017 and has held it in 4 quarters since.
  • Inspire Investing's Cellectis position peaked at $1K in Q4 2017.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.